Light therapy conquers resistance to anticancer drugs
This article was originally published in Clinica
Executive Summary
A combination of chemotherapy and photoimmunotherapy could be used to treat patients with ovarian cancer who do not respond to drug therapy alone, say researchers at Harvard Medical School in Boston, Massachusetts. Ovarian cancer patients, who are resistant to cisplatin-based chemotherapy, have little hope being cured.